DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
about
Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageProtection against malaria by immunization with plasmid DNA encoding circumsporozoite proteinPotent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationGene vaccination with naked plasmid DNA: mechanism of CTL primingRole of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoproteinAntibody responses to Brugia malayi antigens induced by DNA vaccinationDNA immunization as a technology platform for monoclonal antibody inductionSynthetic DNA vaccine strategies against persistent viral infectionsDNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in miceEnhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed miceEnhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c MiceDNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsidImmune responses to plasmid DNA encoding the hepatitis C virus core proteinImmunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection modeNaked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challengeProphylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.DNA vaccine for cancer immunotherapyMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesAmiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cellsLaser plasma jet driven microparticles for DNA/drug deliveryGM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primatesHuman Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B EnvelopeVaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routesTechnological Microbiology: Development and ApplicationsHeterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.Prospects for developing an effective particle-mediated DNA vaccine against influenza.Animal models for the preclinical evaluation of candidate influenza vaccines.Vaccine design for CD8 T lymphocyte responsesDNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.Physical methods of nucleic acid transfer: general concepts and applicationsEliciting an immune response by plasmid DNA encoding a human sperm protein (HSD-1).Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in miceImmunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.Advancement and prospects of tumor gene therapyGenes that induce immunity--DNA vaccines.Immunological properties of gene vaccines delivered by different routes.
P2860
Q24514954-72AC2EBA-F593-4DC9-9EE7-E3C76BFF7B9DQ24531468-8813B99D-A919-4951-9D2F-46F3DFA2650EQ24563514-8B58C2B9-E033-4743-B38F-049082E6C407Q24646818-BDDD3C8C-56E3-427B-B97E-4BD635B2A271Q24676957-3EEEA78A-08FD-47D9-8EC3-58413C3526C5Q24679494-8CA96FC7-1D70-4346-A8E9-552B1DE7B76EQ24797438-27C02E05-51F3-48AE-A676-178E97D3AE58Q26751432-D4E4585D-210A-44EC-9476-2F9FA498DF02Q27016078-2CBE1F5D-1B7B-4444-8334-533A6E0CA62BQ27469515-D244D701-51A6-4123-87AF-CD13F9981AF4Q27469642-8534EF2F-1A9F-4AFE-9DFC-116782E7C9C4Q27469698-EA6A13B9-D952-4A0B-BB57-8C09823BEC2BQ27473373-D0EBC085-E09B-4998-809E-22EC2A1BBF47Q27480298-0DF9B113-53C1-4905-956E-348566518DA4Q27480300-A7736CE9-2551-4BF8-AC78-7AAE51D22424Q27480864-82A934E2-1C8E-4928-9A42-51D85DA0EDE9Q27485866-C768C499-48BE-4C3E-807C-FED4EE7A016FQ27488288-82AABC8B-B9AD-4DAD-A810-B9C3CDC789F3Q28080919-059F6674-D0D0-4068-92C0-9EBB6BE84C60Q28294355-9394DCD9-D352-454C-9FDF-CEA5DD7F632CQ28481556-95D51E45-A570-447C-AFCB-77D061BFD4FAQ28485400-6B01523F-0E88-4209-BAB2-C466FEDE13ACQ28751705-97DCD060-7B33-44D5-8523-DF4234140E1BQ29307502-9D3033CD-5FF2-49B5-8F12-23B34AB823F8Q30096805-3F966664-D60C-4B61-AC72-9BF274480D4AQ30250972-9E475138-0CA7-4527-9B6D-EF0401CBB1DDQ30369828-C4C22130-5407-43C9-83CD-D31F4F8AE0C1Q30375982-619940C8-F609-488A-92E6-59EF97F42C6CQ30380300-54DB63FA-4C02-42BF-84C6-826D695B8506Q30383623-B1DB454F-ED9F-4134-8B10-18EE036B9D6BQ30411492-8053189F-D22B-4A85-A45D-5DE190CF9D18Q30432708-1100DAA8-5187-4E0E-A523-181E20F8F3C6Q30481629-422C5FAE-90E9-4284-A951-BD88BB9A7EB0Q30735542-47D13438-AD63-48DB-BE01-B788B0D4069BQ33348633-CDE1B30D-9FF6-4968-8BB1-2F023FC01FDEQ33409110-8223AB85-7B04-4F12-8832-D04DB411AE2EQ33490614-56F4CCEC-C7E9-4B64-91E9-E4762BB36FC8Q33579330-289A2932-5820-4CED-9AB5-6C4E0C47357CQ33641393-03CBEC18-FD49-4296-AE44-2BAEC57C36EBQ33646664-470A43FA-F7A7-43F7-920E-EC559059E5A3
P2860
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@ast
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@en
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@nl
type
label
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@ast
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@en
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@nl
prefLabel
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@ast
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@en
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@nl
P2093
P2860
P3181
P356
P1476
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
@en
P2093
D H Fuller
H L Robinson
J C Santoro
J R Haynes
R G Webster
P2860
P304
P3181
P356
10.1073/PNAS.90.24.11478
P407
P577
1993-12-15T00:00:00Z